Brand Asset Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
1,023
-17
-2% -$3.66K 0.06% 191
2026
Q1
$226K Buy
1,040
+10
+1% +$2.22K 0.06% 182
2025
Q4
$235K Buy
+1,030
New +$235K 0.07% 157
2021
Q2
– Sell
-980
Closed -$106K – 78
2021
Q1
$106K Buy
980
+330
+51% +$35.3K 0.05% 99
2020
Q4
$70K Sell
650
-273
-30% -$26.2K 0.04% 100
2020
Q3
$81K Buy
923
+264
+40% +$24.9K 0.05% 97
2020
Q2
$65K Hold
659
– – 0.04% 103
2020
Q1
$50K Hold
659
– – 0.04% 108
2019
Q4
$58K Hold
659
– – 0.04% 127
2019
Q3
$50K Sell
659
-86
-12% -$5.9K 0.03% 135
2019
Q2
$54K Hold
745
– – 0.04% 126
2019
Q1
$60K Sell
745
-314
-30% -$25.7K 0.04% 113
2018
Q4
$98K Buy
1,059
+400
+61% +$35.2K 0.08% 83
2018
Q3
$62K Hold
659
– – 0.05% 105
2018
Q2
$61K Buy
+659
New +$64.4K 0.05% 110

Other funds holding ABBV

Brand Asset Management Group's ABBV Position: Q2 2026 in Review

Brand Asset Management Group reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $3.66K and leaving 1,023 shares worth $257K. The position accounts for 0.06% of the portfolio, ranked #191.

Brand Asset Management Group first reported a position in ABBV in Q2 2018 and has held it in 15 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brand Asset Management Group held 1,023 shares of AbbVie worth $257K as of Q2 2026.
  • Brand Asset Management Group sold 17 AbbVie shares in Q2 2026, an estimated $3.66K.
  • AbbVie made up 0.06% of Brand Asset Management Group's portfolio in Q2 2026, its #191 holding.
  • Brand Asset Management Group first reported a position in AbbVie in Q2 2018 and has held it in 15 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brand Asset Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.